157 related articles for article (PubMed ID: 26176235)
1. Chemically Modified Plastic Tube for High Volume Removal and Collection of Circulating Tumor Cells.
Gaitas A; Kim G
PLoS One; 2015; 10(7):e0133194. PubMed ID: 26176235
[TBL] [Abstract][Full Text] [Related]
2. Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip.
Sheng W; Ogunwobi OO; Chen T; Zhang J; George TJ; Liu C; Fan ZH
Lab Chip; 2014 Jan; 14(1):89-98. PubMed ID: 24220648
[TBL] [Abstract][Full Text] [Related]
3. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
[TBL] [Abstract][Full Text] [Related]
4. Microtube device for selectin-mediated capture of viable circulating tumor cells from blood.
Hughes AD; Mattison J; Western LT; Powderly JD; Greene BT; King MR
Clin Chem; 2012 May; 58(5):846-53. PubMed ID: 22344286
[TBL] [Abstract][Full Text] [Related]
5. Size-selective collection of circulating tumor cells using Vortex technology.
Sollier E; Go DE; Che J; Gossett DR; O'Byrne S; Weaver WM; Kummer N; Rettig M; Goldman J; Nickols N; McCloskey S; Kulkarni RP; Di Carlo D
Lab Chip; 2014 Jan; 14(1):63-77. PubMed ID: 24061411
[TBL] [Abstract][Full Text] [Related]
6. SSA-MOA: a novel CTC isolation platform using selective size amplification (SSA) and a multi-obstacle architecture (MOA) filter.
Kim MS; Sim TS; Kim YJ; Kim SS; Jeong H; Park JM; Moon HS; Kim SI; Gurel O; Lee SS; Lee JG; Park JC
Lab Chip; 2012 Aug; 12(16):2874-80. PubMed ID: 22684249
[TBL] [Abstract][Full Text] [Related]
7. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
[TBL] [Abstract][Full Text] [Related]
8. Efficient capture and simple quantification of circulating tumor cells using quantum dots and magnetic beads.
Min H; Jo SM; Kim HS
Small; 2015 Jun; 11(21):2536-42. PubMed ID: 25630488
[TBL] [Abstract][Full Text] [Related]
9. Molecular Profiling of Pooled Circulating Tumor Cells from Prostate Cancer Patients Using a Dual-Antibody-Functionalized Microfluidic Device.
Yin C; Wang Y; Ji J; Cai B; Chen H; Yang Z; Wang K; Luo C; Zhang W; Yuan C; Wang F
Anal Chem; 2018 Mar; 90(6):3744-3751. PubMed ID: 29464943
[TBL] [Abstract][Full Text] [Related]
10. Immunofunctional photodegradable poly(ethylene glycol) hydrogel surfaces for the capture and release of rare cells.
LeValley PJ; Tibbitt MW; Noren B; Kharkar P; Kloxin AM; Anseth KS; Toner M; Oakey J
Colloids Surf B Biointerfaces; 2019 Feb; 174():483-492. PubMed ID: 30497010
[TBL] [Abstract][Full Text] [Related]
11. A platform for primary tumor origin identification of circulating tumor cells via antibody cocktail-based in vivo capture and specific aptamer-based multicolor fluorescence imaging strategy.
Jia M; Mao Y; Wu C; Wang S; Zhang H
Anal Chim Acta; 2019 Nov; 1082():136-145. PubMed ID: 31472702
[TBL] [Abstract][Full Text] [Related]
12. Isolation and mutational analysis of circulating tumor cells from lung cancer patients with magnetic sifters and biochips.
Earhart CM; Hughes CE; Gaster RS; Ooi CC; Wilson RJ; Zhou LY; Humke EW; Xu L; Wong DJ; Willingham SB; Schwartz EJ; Weissman IL; Jeffrey SS; Neal JW; Rohatgi R; Wakelee HA; Wang SX
Lab Chip; 2014 Jan; 14(1):78-88. PubMed ID: 23969419
[TBL] [Abstract][Full Text] [Related]
13. Antibody-Modified Reduced Graphene Oxide Films with Extreme Sensitivity to Circulating Tumor Cells.
Li Y; Lu Q; Liu H; Wang J; Zhang P; Liang H; Jiang L; Wang S
Adv Mater; 2015 Nov; 27(43):6848-54. PubMed ID: 26426823
[TBL] [Abstract][Full Text] [Related]
14. Enhanced tumor cell isolation by a biomimetic combination of E-selectin and anti-EpCAM: implications for the effective separation of circulating tumor cells (CTCs).
Myung JH; Launiere CA; Eddington DT; Hong S
Langmuir; 2010 Jun; 26(11):8589-96. PubMed ID: 20155985
[TBL] [Abstract][Full Text] [Related]
15. Biocompatible TiO2 nanoparticle-based cell immunoassay for circulating tumor cells capture and identification from cancer patients.
He R; Zhao L; Liu Y; Zhang N; Cheng B; He Z; Cai B; Li S; Liu W; Guo S; Chen Y; Xiong B; Zhao XZ
Biomed Microdevices; 2013 Aug; 15(4):617-626. PubMed ID: 23780622
[TBL] [Abstract][Full Text] [Related]
16. Real-time circulating tumor cells detection via highly sensitive needle-like cytosensor-demonstrated by a blood flow simulation.
Weng WH; Ho IL; Pang CC; Pang SN; Pan TM; Leung WH
Biosens Bioelectron; 2018 Sep; 116():51-59. PubMed ID: 29859397
[TBL] [Abstract][Full Text] [Related]
17. Microfluidic immunocapture of circulating pancreatic cells using parallel EpCAM and MUC1 capture: characterization, optimization and downstream analysis.
Thege FI; Lannin TB; Saha TN; Tsai S; Kochman ML; Hollingsworth MA; Rhim AD; Kirby BJ
Lab Chip; 2014 May; 14(10):1775-84. PubMed ID: 24681997
[TBL] [Abstract][Full Text] [Related]
18. Site-specific antibody modification and immobilization on a microfluidic chip to promote the capture of circulating tumor cells and microemboli.
Lai CH; Choon Lim S; Wu LC; Wang CF; Tsai WS; Wu HC; Chang YC
Chem Commun (Camb); 2017 Apr; 53(29):4152-4155. PubMed ID: 28352905
[TBL] [Abstract][Full Text] [Related]
19. A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells.
Kang JH; Krause S; Tobin H; Mammoto A; Kanapathipillai M; Ingber DE
Lab Chip; 2012 Jun; 12(12):2175-81. PubMed ID: 22453808
[TBL] [Abstract][Full Text] [Related]
20. Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen.
Johnson ES; Anand RK; Chiu DT
Anal Chem; 2015 Sep; 87(18):9389-95. PubMed ID: 26302174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
